General Information of the Compound
Compound ID
CP0547784
Compound Name
[2-[4-fluoro-3-(trifluoromethyl)anilino]-4-pyridin-4-yl-1,3-thiazol-5-yl]methanol
    Show/Hide
Synonyms
Alpha-7 nicotinic acetylcholine receptor modulator (cognitive disorder), Johnson & Johnson
JNJ-1930942
JNJ-41512549
    Show/Hide
Structure
Formula
C16H11F4N3OS
Molecular Weight
369.343
Canonical SMILES
OCc1sc(Nc2ccc(F)c(c2)C(F)(F)F)nc1-c1ccncc1
    Show/Hide
InChI
InChI=1S/C16H11F4N3OS/c17-12-2-1-10(7-11(12)16(18,19)20)22-15-23-14(13(8-24)25-15)9-3-5-21-6-4-9/h1-7,24H,8H2,(H,22,23)
    Show/Hide
InChIKey
JBSVHWCIKVSTTH-UHFFFAOYSA-N
Physicochemical Property
logP
4.5989
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
58.04
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44240744
SID: 85260670
ChEMBL ID
CHEMBL270479
Clinical Information about the Compound
Drug 1 ( JNJ-1930942 )
Drug Name JNJ-1930942
Company Johnson & Johnson
Indication
Cognitive impairment
Investigative
Target(s)
Neuronal acetylcholine receptor alpha-7 (CHRNA7)
Modulator